Pictured: Stack of $100 bills / iStock, Nattakorn Maneerat Verona Pharma, a biotech working on treating chronic obstructive pulmonary disease, has been given a financial boost of up to $400 million from two capital firms, the company announced Tuesday. Under a debt financing facility, Verona will receive up to$400 million from funds that Oxford Finance and